Serge Saxonov net worth and biography

Serge Saxonov Biography and Net Worth

CEO of 10x Genomics
Serge Saxonov co-founded 10x Genomics in 2012. As the CEO, he defined the 10x vision and strategy, contributed to core inventions, and has led the company since inception. Prior to 10x Genomics, Serge was Vice President of Applications at QuantaLife, where he built products and defined the company’s growth areas. Serge was the first employee at 23andMe, where he served as Founding Architect and Director of R&D. There he defined the initial concept of the product, built out the core technology, and drove strategy and execution of R&D functions. Serge received a Ph.D. in biomedical informatics from Stanford University and an A.B. in applied mathematics from Harvard College.

What is Serge Saxonov's net worth?

The estimated net worth of Serge Saxonov is at least $34.05 million as of November 22nd, 2022. Dr. Saxonov owns 974,926 shares of 10x Genomics stock worth more than $34,054,165 as of December 9th. This net worth approximation does not reflect any other assets that Dr. Saxonov may own. Additionally, Dr. Saxonov receives a salary of $736,520.00 as CEO at 10x Genomics. Learn More about Serge Saxonov's net worth.

How old is Serge Saxonov?

Dr. Saxonov is currently 45 years old. There are 3 older executives and no younger executives at 10x Genomics. Learn More on Serge Saxonov's age.

What is Serge Saxonov's salary?

As the CEO of 10x Genomics, Inc., Dr. Saxonov earns $736,520.00 per year. Learn More on Serge Saxonov's salary.

How do I contact Serge Saxonov?

The corporate mailing address for Dr. Saxonov and other 10x Genomics executives is 6230 STONERIDGE MALL ROAD, PLEASANTON CA, 94588. 10x Genomics can also be reached via phone at 925-401-7300 and via email at [email protected] Learn More on Serge Saxonov's contact information.

Has Serge Saxonov been buying or selling shares of 10x Genomics?

During the past quarter, Serge Saxonov has sold $91,171.32 in 10x Genomics stock. Most recently, Serge Saxonov sold 2,676 shares of the business's stock in a transaction on Tuesday, November 22nd. The shares were sold at an average price of $34.07, for a transaction totalling $91,171.32. Following the completion of the sale, the chief executive officer now directly owns 974,926 shares of the company's stock, valued at $33,215,728.82. Learn More on Serge Saxonov's trading history.

Who are 10x Genomics' active insiders?

10x Genomics' insider roster includes Bradford Crutchfield (Insider), Benjamin Hindson (Insider), Sridhar Kosaraju (Director), Justin McAnear (CFO), Serge Saxonov (CEO), and John Stuelpnagel (Director). Learn More on 10x Genomics' active insiders.

Are insiders buying or selling shares of 10x Genomics?

During the last year, 10x Genomics insiders bought shares 1 times. They purchased a total of 158 shares worth more than $6,397.42. During the last year, insiders at the sold shares 19 times. They sold a total of 147,409 shares worth more than $17,490,624.47. The most recent insider tranaction occured on November, 22nd when CEO Serge Saxonov sold 2,676 shares worth more than $91,171.32. Insiders at 10x Genomics own 11.1 % of the company. Learn More about insider trades at 10x Genomics.

Information on this page was last updated on 11/22/2022.

Serge Saxonov Insider Trading History at 10x Genomics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/22/2022Sell2,676$34.07$91,171.32974,926View SEC Filing Icon  
8/23/2022Sell2,715$35.19$95,540.85966,102View SEC Filing Icon  
5/23/2022Sell2,656$48.76$129,506.56968,817View SEC Filing Icon  
2/22/2022Sell551$78.60$43,308.60View SEC Filing Icon  
2/8/2022Sell12,000$89.90$1,078,800.00View SEC Filing Icon  
1/4/2022Sell15,000$141.33$2,119,950.00View SEC Filing Icon  
12/7/2021Sell15,000$145.97$2,189,550.00View SEC Filing Icon  
11/22/2021Sell772$148.38$114,549.36View SEC Filing Icon  
11/2/2021Sell15,000$161.25$2,418,750.00View SEC Filing Icon  
10/5/2021Sell15,000$143.50$2,152,500.00View SEC Filing Icon  
9/7/2021Sell15,000$188.42$2,826,300.00View SEC Filing Icon  
8/23/2021Sell742$161.85$120,092.70View SEC Filing Icon  
7/6/2021Sell15,000$193.08$2,896,200.00View SEC Filing Icon  
6/8/2021Sell15,000$186.37$2,795,550.00904,068View SEC Filing Icon  
5/24/2021Sell771$162.66$125,410.86View SEC Filing Icon  
5/4/2021Sell15,000$184.08$2,761,200.00885,676View SEC Filing Icon  
4/6/2021Sell15,000$195.81$2,937,150.00885,676View SEC Filing Icon  
2/1/2021Sell10,000$176.00$1,760,000.00889,576View SEC Filing Icon  
1/4/2021Sell10,000$139.93$1,399,300.00890,468View SEC Filing Icon  
12/1/2020Sell10,000$151.40$1,514,000.00973,431View SEC Filing Icon  
11/2/2020Sell7,076$136.35$964,812.60973,431View SEC Filing Icon  
9/1/2020Sell10,000$113.97$1,139,700.00955,821View SEC Filing Icon  
8/3/2020Sell10,000$99.33$993,300.00963,181View SEC Filing Icon  
7/1/2020Sell10,000$87.58$875,800.00963,181View SEC Filing Icon  
6/1/2020Sell10,000$79.82$798,200.00963,181View SEC Filing Icon  
5/1/2020Sell10,000$77.39$773,900.00955,514View SEC Filing Icon  
4/1/2020Sell10,000$58.07$580,700.00960,514View SEC Filing Icon  
3/6/2020Sell10,000$65.14$651,400.00946,347View SEC Filing Icon  
See Full Table

Serge Saxonov Buying and Selling Activity at 10x Genomics

This chart shows Serge Saxonov's buying and selling at 10x Genomics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

10x Genomics Company Overview

10x Genomics logo
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Read More

Today's Range

Now: $34.93
Low: $34.69
High: $38.31

50 Day Range

MA: $32.09
Low: $24.40
High: $41.30

2 Week Range

Now: $34.93
Low: $23.81
High: $154.10

Volume

1,845,248 shs

Average Volume

1,387,606 shs

Market Capitalization

$4.00 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.7